siRNA-encapsulated immunoliposomes conjugated with CD44 antibodies target and eliminate gastric cancer-initiating cells

about

siRNA-encapsulated immunoliposomes conjugated with CD44 antibodies target and eliminate gastric cancer-initiating cells

Item

http://www.wikidata.org/entity/Q57816012

description

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

siRNA-encapsulated immunolipos ...... astric cancer-initiating cells

@en

siRNA-encapsulated immunolipos ...... astric cancer-initiating cells

@nl

type

Item

label

siRNA-encapsulated immunolipos ...... astric cancer-initiating cells

@en

siRNA-encapsulated immunolipos ...... astric cancer-initiating cells

@nl

prefLabel

siRNA-encapsulated immunolipos ...... astric cancer-initiating cells

@en

siRNA-encapsulated immunolipos ...... astric cancer-initiating cells

@nl

P1476

siRNA-encapsulated immunolipos ...... astric cancer-initiating cells

@en

P2093

Feng Yang

http://www.w3.org/2001/XMLSchema#string

Guoen Fang

http://www.w3.org/2001/XMLSchema#string

Haijia Li

http://www.w3.org/2001/XMLSchema#string

Jianmin Qin

http://www.w3.org/2001/XMLSchema#string

Jie Gao

http://www.w3.org/2001/XMLSchema#string

Luming Zheng

http://www.w3.org/2001/XMLSchema#string

Xuchao Xue

http://www.w3.org/2001/XMLSchema#string

Zhi Zheng

http://www.w3.org/2001/XMLSchema#string

P2860

Lyophilized HER2-specific PEGylated immunoliposomes for active siRNA gene silencing.

Liposomal drug delivery systems: an update review.

Akt-signal integration is involved in the differentiation of embryonal carcinoma cells

Gene therapy progress and prospects: nonviral vectors.

Gastric cancer: epidemiology, pathology and treatment.

Special AT-rich sequence-binding protein-1 participates in the maintenance of breast cancer stem cells through regulation of the Notch signaling pathway and expression of Snail1 and Twist1.

HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician's choice plus trastuzumab in patients with previously treated, anthracycline-naïve, HER2-positive, locally advanced/metastatic breast cancer.

Interleukin 6 signaling regulates promyelocytic leukemia protein gene expression in human normal and cancer cells.

Selective gene delivery for cancer therapy using cationic liposomes: in vivo proof of applicability.

Gene therapy progress and prospects: non-viral gene therapy by systemic delivery.

P304

6811-6825

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S182437

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30349314

http://www.w3.org/2001/XMLSchema#string

P932

6188175

http://www.w3.org/2001/XMLSchema#string